Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 10, 2010 - Issue 3
Submit an article Journal homepage
130
Views
9
CrossRef citations to date
0
Altmetric
Review

Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy

Steven Simoens Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, O&N 2 P.O. Box 521, Herestraat 49, 3000 Leuven, Belgium. [email protected]
Pages 309-315 | Published online: 09 Jan 2014

References

  • Hauser W, Hesdorffer D. Facts About Epilepsy. The Epilepsy Foundation, MD USA (1994).
  • National Institute for Health and Clinical Excellence. Newer Drugs for Epilepsy in Adults (Technology Appraisal 76). NICE, London, UK (2004).
  • Hauser W. Epilepsy: Frequency, Causes, and Consequences. Demos Press, NY, USA (1990).
  • Hitiris N, Mohanraj R, Norrie J, Brodie MJ. Mortality in epilepsy. Epilepsy Behav.10(3), 363–376 (2007).
  • Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia48(12), 2224–2233 (2007).
  • Brodie MJ, Dichter MA. Established antiepileptic drugs. Seizure6(3), 159–174 (1997).
  • Perucca E, Meador KJ. Adverse effects of antiepileptic drugs. Acta Neurol. Scand. Suppl.181, 30–35 (2005).
  • French JA. Refractory epilepsy: one size does not fit all. Epilepsy Curr.6(6), 177–180 (2006).
  • Brodie MJ. Modern approaches to epilepsy management. Eur. Neurol. Dis.31–32 (2006).
  • Brodie MJ. Epilepsy: randomised trials and genetic tribulations. Lancet Neurol.7(1), 7–8 (2008).
  • Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol.13(3), 277–282 (2006).
  • Leppik I, Morrell M, Godfroid P, Arrigo C. Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy. Epilepsia44(10), 1350–1352 (2003).
  • Wilby J, Kainth A, Hawkins N et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol. Assess.9(15), 1–157, III–IV (2005).
  • Drummond M, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd Edition). Oxford University Press, Oxford, UK (2005).
  • Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ313(7052), 275–283 (1996).
  • Beghi E, Atzeni L, Garattini L. Economic analysis of newer antiepileptic drugs. CNS Drugs22(10), 861–875 (2008).
  • Spackman D, Yeates A, Rentz A, Hutton J. The cost effectiveness of zonisamide as adjunctive therapy in adult partial seizure epilepsy. J. Med. Econ.10, 455–473 (2007).
  • Vera-Llonch M, Brandenburg NA, Oster G. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Epilepsia49(3), 431–437 (2008).
  • SP667/Phase 2/multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to investigate the efficacy and safety of lacosamide (200, 400 and 600 mg/day). Company data on file: UCB Pharma, Brussels, Belgium (2009).
  • SP754/Phase 3/multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to investigate the efficacy and safety of lacosamide (400 and 600 mg/day). Company data on file: UCB Pharma, Brussels, Belgium (2009).
  • SP755/Phase 3/multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to investigate the efficacy and safety of lacosamide (200 and 400 mg/day). Company data on file: UCB Pharma, Brussels, Belgium (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.